Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia

References

• ChowTWHynanLSLiptonAMMMSE scores decline at a greater rate in frontotemporal lobar degeneration than in ADDement Geriatr Cogn Disord200622319419916899996
   PubMed Web of Science ®Google Scholar
• CaycedoAMMillerBKramerJRascovskyKEarly features in frontotemporal dementiaCurr Alzheimer Res20096433734019689232
   PubMed Web of Science ®Google Scholar
• Gorno-TempiniMLHillisAEWeintraubSClassification of primary progressive aphasia and its variantsNeurology201176111006101421325651
   PubMed Web of Science ®Google Scholar
• KayeEDPetrovic-PoljakcAVerhoeffNPLGFreedmanMFrontotemporal dementia and pharmacologic interventionsJ Neuropsychiatry Clin Neurosci2010221192920160206
   PubMed Web of Science ®Google Scholar
• TariotPNFarlowMRGrossbergGTMemantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trialJAMA2004291331732414734594
   PubMed Web of Science ®Google Scholar
• KuszczykMSlomkaMAntkiewicz-MichalukLSalinskaELazarewiczJW1-Methyl-1,2,3,4-tetrahydroisoquinoline and established uncompetitive NMDA receptor antagonists induce tolerance to excito-toxicityPharmacol Rep20106261041105021273661
   PubMed Web of Science ®Google Scholar
• LiptonSAPathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylationCurr Drug Targets20078562163217504105
   PubMed Web of Science ®Google Scholar
• NakamuraTLiptonSAEmerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseasesAntioxid Redox Signal20081018710117961071
   PubMed Web of Science ®Google Scholar
• RammesGHasenjagerASroka-SaidiKDeussingJParsonsCGTherapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synapto-toxic effects of beta-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slicesNeuropharmacology201160698299021310164
   PubMed Web of Science ®Google Scholar
• OnogiHIshigakiSNakagawasaiOInfluence of memantine on brain monoaminergic neurotransmission parameters in mice: Neurochemical and behavioral studyBiol Pharm Bull200932585085519420753
   PubMed Web of Science ®Google Scholar
• WilcockGMobiusHJStofflerAA double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)Int Clin Psychopharmacol200217629730512409683
   PubMed Web of Science ®Google Scholar
• OrgogozoJMRigaudASStofflerAMobiusHJForetteFEfficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300)Stroke20023371834183912105362
   PubMed Web of Science ®Google Scholar
• HuntleyGWVickersJCJanssenWBroseNHeinemannSFMorrisonJHDistribution and synaptic localization of immunocytochemically identified NMDA receptor subunit proteins in sensory-motor and visual cortices of monkey and humanJ Neurosci1994146360336198207475
   PubMed Web of Science ®Google Scholar
• BohnenNIKoeppeRAMinoshimaSCerebral glucose metabolic features of parkinson disease and incident dementia: longitudinal studyJ Nucl Med201152684885521571793
   PubMed Web of Science ®Google Scholar
• HerholzKCerebral glucose metabolism in preclinical and prodromal Alzheimer’s diseaseExpert Rev Neurother201010111667167320977325
   PubMed Web of Science ®Google Scholar
• HerholzKPeraniDSalmonEComparability of FDG PET studies in probable Alzheimer’s diseaseJ Nucl Med1993349146014668355064
   PubMed Web of Science ®Google Scholar
• JagustWJBandyDChenKThe Alzheimer’s Disease Neuroimaging Initiative positron emission tomography coreAlzheimers Dement20106322122920451870
   PubMed Web of Science ®Google Scholar
• AlexanderGEChenKPietriniPRapoportSIReimanEMLongitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer’s disease treatment studiesAm J Psychiatry2002159573874511986126
   PubMed Web of Science ®Google Scholar
• De LeonMJFerrisSHGeorgeAEComputed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer’s diseaseJ Cereb Blood Flow Metab1983333913946603463
   PubMed Web of Science ®Google Scholar
• MosconiLMisturRSwitalskiRFDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s diseaseEur J Nucl Med Mol Imaging200936581182219142633
   PubMed Web of Science ®Google Scholar
• HaxbyJVGradyCLKossELongitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer typeArch Neurol19904777537602357155
   PubMedGoogle Scholar
• VillainNFouquetMBaronJCSequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer’s diseaseBrain2010133113301331420688814
   PubMed Web of Science ®Google Scholar
• ChenKLangbaumJBFleisherASTwelve-month metabolic declines in probable Alzheimer’s disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of- interest: findings from the Alzheimer’s Disease Neuroimaging InitiativeNeuroimage201051265466420202480
   PubMed Web of Science ®Google Scholar
• SalmonEKerroucheNHerholzKDecomposition of metabolic brain clusters in the frontal variant of frontotemporal dementiaNeuroimage200630387187816359874
   PubMed Web of Science ®Google Scholar
• FranceschiMAnchisiDPelatiOGlucose metabolism and serotonin receptors in the frontotemporal lobe degenerationAnn Neurol200557221622515668960
   PubMed Web of Science ®Google Scholar
• PasquierFFukuiTSarazinMLaboratory investigations and treatment in frontotemporal dementiaAnn Neurol200354S5S323512833367
   PubMed Web of Science ®Google Scholar
• ZhouJGreiciusMGennatasEDivergent network connectivity changes in behavioral variant frontotemporal dementia and Alzheimer’s diseaseBrain2010133Pt 51352136720410145
   PubMed Web of Science ®Google Scholar
• NearyDSnowdenJSGustafsonLFrontotemporal lobar degeneration: a consensus on clinical diagnostic criteriaNeurology1998516154615549855500
   PubMed Web of Science ®Google Scholar
• MorrisJCThe Clinical Dementia Rating (CDR): current version and scoring rulesNeurology19934311241224148232972
   PubMed Web of Science ®Google Scholar
• WinbladBPoritisNMemantine in severe dementia: Results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine)Int J Geriatr Psychiatry199914213514610885864
   PubMed Web of Science ®Google Scholar
• LundbeckEbixa® (memantine)Product Monograph2002
   Google Scholar
• KerteszADavidsonWFoxHFrontal behavioral inventory: diagnostic criteria for frontal lobe dementiaCan J Neurol Sci199724129369043744
   PubMed Web of Science ®Google Scholar
• ShigenobuKIkedaMFukuharaRThe Stereotypy Rating Inventory for frontotemporal lobar degenerationPsychiatry Res2002110217518712057829
   PubMed Web of Science ®Google Scholar
• DuboisBSlachevskyALitvanIPillonBThe FAB: a Frontal Assessment Battery at bedsideNeurology200055111621162611113214
   PubMed Web of Science ®Google Scholar
• Martinez-MartinPGil-NagelAGraciaLMGomezJBMartinez-SarriesJBermejoFUnified Parkinson’s disease Rating Scale characteristics and structure. The Cooperative Multicentric GroupMov Disord19949176838139608
   PubMed Web of Science ®Google Scholar
• Graff-GuerreroADe la Fuente-SandovalCCamarenaBFrontal and limbic metabolic differences in subjects selected according to genetic variation of the SLC6A4 gene polymorphismNeuroimage20052541197120415850737
   PubMed Web of Science ®Google Scholar
• ChowTWCummingsJLFrontal-subcortical circuitsMillerBLCummingsJLThe Human Frontal Lobes: Functions and Disorders2nd edNew YorkGuilford Press2006
   Google Scholar
• BuchsbaumMSHaznedarMNewmarkREFDG-PET and MRI imaging of the effects of sertindole and haloperidol in the prefrontal lobe in schizophreniaSchizophr Res20091141316117119683417
   PubMed Web of Science ®Google Scholar
• MegaMSDinovIDPorterVMetabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose F18 positron emission tomographic studyArch Neurol200562572172815883258
   PubMedGoogle Scholar
• SultzerDLMelroseRJHarwoodDGCampaOMandelkernMAEffect of memantine treatment on regional cortical metabolism in Alzheimer’s diseaseAm J Geriatr Psychiatry201018760661420220580
   PubMed Web of Science ®Google Scholar
• StussDTMurphyKJBinnsMAAlexanderMPStaying on the job: The frontal lobes control individual performance variabilityBrain2003126Pt 112363238012876148
   PubMed Web of Science ®Google Scholar
• GauthierSWirthYMöbiusHJEffects of memantine on behavioural symptoms in Alzheimer’s disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studiesInt J Geriatr Psychiatry200520545946415852444
   PubMed Web of Science ®Google Scholar
• CummingsJLSchneiderETariotPNGrahamSMMemantine MEMMD- 02 Study Group. Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatmentNeurology2006671576316832078
   PubMed Web of Science ®Google Scholar
• Diehl-SchmidJFörstlHPerneczkyRPohlCKurzAA 6-month, open-label study of memantine in patients with frontotemporal dementiaInt J Geriatr Psychiatry200823775475918213609
   PubMed Web of Science ®Google Scholar
• ScharreJWKnickJADavisRATheado-MillerNMemantine in frontotemporal dementiaNeurology200564A99
   Web of Science ®Google Scholar
• SwanbergMMMemantine for behavioral disturbances in frontotemporal dementia: a case seriesAlzheimer Dis Assoc Disord200721216416617545743
   PubMed Web of Science ®Google Scholar
• BoxerALLiptonAMWomackKAn open-label study of memantine treatment in 3 subtypes of frontotemporal lobar degenerationAlzheimer Dis Assoc Disord200923321121719812461
   PubMed Web of Science ®Google Scholar
• VercellettoMBoutoleau-BretonniereCVolteauCMemantine in behavioral variant frontotemporal dementia: negative resultsJ Alzheimers Dis201123474975921157021
   PubMed Web of Science ®Google Scholar
• Diehl-SchmidJGrimmerTDrzezgaADecline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18FFDG- PET-studyNeurobiol Aging2007281425016448722
   PubMed Web of Science ®Google Scholar
• KnopmanDSJackCRJrKramerJHBrain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 yearNeurology200972211843184919470967
   PubMed Web of Science ®Google Scholar
• AisenPSPetersenRCDonohueMCClinical core of the Alzheimer’s Disease Neuroimaging Initiative: progress and plansAlzheimers Dement20106323924620451872
   PubMed Web of Science ®Google Scholar